Ing the epidemics of the four types of JSI-124 site seasonal influenza viruses, we showed that the ILIs, which were mainly composed of seasonal B/Y and seasonal H1N1 in March, decreased rapidly in August and September (Figure 1 and Figure 2). This partly explains why the antibodies in the patients against A/H3N2, B/Y Table 9. Change of B/Victoria Antibody Titer Level 
25033180 Between March and September by Age Group (mean titer value in log2 scale).and B/V decreased in September. It seems that the antibodies against 2009 H1N1 could cross-react with the seasonal influenza A/H1N1 because the antibodies against A/H1N1 were at similar levels both in March and September. This is not surprising because both the seasonal A/H1N1 and A/sH1N1 share much closer epitopes than the A/H3N2, B/Y and B/V subtypes. We also noted that the antibody titers of H3N2 markedly decreased in September compared to those in March, although the H3N2 went through a peak in July, and the infection rate in September was similar to that in March. However, the underlying mechanism was not clear. There was no Itacitinib web difference between the male and the female group in general; however, for seasonal A/H1N1, the antibody titer dropped much more in male than in female. It is generally reported that the number of incidences of the 2009 H1N1 infection was greater in males than in females; nevertheless, the severity of the infection was greater in the female cases [21]. A Canadian study reported that among the critically ill cases of 2009 H1N1, 74 of the deaths were female [22]. It may be suggested that females should be provided with greater protection against seasonal influenza virus infections. Of course, more data from other populations needs to be collected to confirm these phenomena. When splitting the participants into age groups, we observed that the 15?5 and the 26?9 age groups had the highest seroprevalence of seasonal influenza before the pandemic, and during the pandemic the 0? and the 60 age groups had the highest seroprevalence. In particular, the 0? age group had increased antibody levels for all types of seasonal influenza during the pandemic, in contrast to almost all other age groups (exceptAge group/Group mean in log2 scale 0? March September Difference P-value Bonferroni Adjusted P-value 3.769 3.6?5 3.451 3.16?5 4.020 3.463 0.557 0.001 0.26?9 3.872 3.472 0.401 0.012 0.60 4.390 3.898 0.492 0.011 0.Table 10. Multivariate regression output: 2009 H1N1 antibody against gender, age, and seasonal influenza antibodies (log transformed scale).Covariates (Constant) Gender AgeBeta 2.287 2.008 .002 .288 2.068 .045 2.Std. Err .126 .069 .002 .037 .040 .033 .t 18.096 2.117 1.p-value .000 .907 .131 .000 .090 .175 .20.105 0.379 0.495 1 0.015 0.H1NH3N2 B.Y B.V7.21.698 1.356 2.Except for the 0? age group, all other age groups showed significantly decreased antibody levels of B/V during the 2009 H1N1 pandemic compared to before the pandemic, using t-test. *boldface indicates an increased antibody level in September compared to that in March. doi:10.1371/journal.pone.0053847.tdoi:10.1371/journal.pone.0053847.tInfluenza Antibodies Reaction during 2009 H1N60 age group in A/H1N1), in which the antibody level decreased. Cross-reactivity of the old and the new H1N1 antibody might be particularly strong in the 0? age group and the 60 age group. It also suggested that the youngest group had an especially high risk of being attacked both by the seasonal influenza and the 2009 H1N1 influenza during its pandemic. F.Ing the epidemics of the four types of seasonal influenza viruses, we showed that the ILIs, which were mainly composed of seasonal B/Y and seasonal H1N1 in March, decreased rapidly in August and September (Figure 1 and Figure 2). This partly explains why the antibodies in the patients against A/H3N2, B/Y Table 9. Change of B/Victoria Antibody Titer Level 25033180 Between March and September by Age Group (mean titer value in log2 scale).and B/V decreased in September. It seems that the antibodies against 2009 H1N1 could cross-react with the seasonal influenza A/H1N1 because the antibodies against A/H1N1 were at similar levels both in March and September. This is not surprising because both the seasonal A/H1N1 and A/sH1N1 share much closer epitopes than the A/H3N2, B/Y and B/V subtypes. We also noted that the antibody titers of H3N2 markedly decreased in September compared to those in March, although the H3N2 went through a peak in July, and the infection rate in September was similar to that in March. However, the underlying mechanism was not clear. There was no difference between the male and the female group in general; however, for seasonal A/H1N1, the antibody titer dropped much more in male than in female. It is generally reported that the number of incidences of the 2009 H1N1 infection was greater in males than in females; nevertheless, the severity of the infection was greater in the female cases [21]. A Canadian study reported that among the critically ill cases of 2009 H1N1, 74 of the deaths were female [22]. It may be suggested that females should be provided with greater protection against seasonal influenza virus infections. Of course, more data from other populations needs to be collected to confirm these phenomena. When splitting the participants into age groups, we observed that the 15?5 and the 26?9 age groups had the highest seroprevalence of seasonal influenza before the pandemic, and during the pandemic the 0? and the 60 age groups had the highest seroprevalence. In particular, the 0? age group had increased antibody levels for all types of seasonal influenza during the pandemic, in contrast to almost all other age groups (exceptAge group/Group mean in log2 scale 0? March September Difference P-value Bonferroni Adjusted P-value 3.769 3.6?5 3.451 3.16?5 4.020 3.463 0.557 0.001 0.26?9 3.872 3.472 0.401 0.012 0.60 4.390 3.898 0.492 0.011 0.Table 10. Multivariate regression output: 2009 H1N1 antibody against gender, age, and seasonal influenza antibodies (log transformed scale).Covariates (Constant) Gender AgeBeta 2.287 2.008 .002 .288 2.068 .045 2.Std. Err .126 .069 .002 .037 .040 .033 .t 18.096 2.117 1.p-value .000 .907 .131 .000 .090 .175 .20.105 0.379 0.495 1 0.015 0.H1NH3N2 B.Y B.V7.21.698 1.356 2.Except 
for the 0? age group, all other age groups showed significantly decreased antibody levels of B/V during the 2009 H1N1 pandemic compared to before the pandemic, using t-test. *boldface indicates an increased antibody level in September compared to that in March. doi:10.1371/journal.pone.0053847.tdoi:10.1371/journal.pone.0053847.tInfluenza Antibodies Reaction during 2009 H1N60 age group in A/H1N1), in which the antibody level decreased. Cross-reactivity of the old and the new H1N1 antibody might be particularly strong in the 0? age group and the 60 age group. It also suggested that the youngest group had an especially high risk of being attacked both by the seasonal influenza and the 2009 H1N1 influenza during its pandemic. F.
